Cytek Biosciences, Inc. (CTKB) vs Tactile Systems Technology, Inc. (TCMD)
- Cytek Biosciences, Inc. CTKB 5.80 +7.41%
- Tactile Systems Technology, Inc. TCMD 25.79 −2.20%
Cytek Biosciences, Inc. and Tactile Systems Technology, Inc. are both Medical Devices companies. Cytek Biosciences, Inc. is the larger, with a market value of $701.9M against $590.7M — 1.2× the size. Cytek Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Tactile Systems Technology, Inc. trades at 25.2×. Tactile Systems Technology, Inc. grew revenue faster over the last twelve months: 14.4% against 5.50%. Tactile Systems Technology, Inc. has the higher net margin (6.68% vs −39.1%) and the higher return on invested capital (15.3% vs −42.1%). Across the 18 metrics below, Tactile Systems Technology, Inc. leads on 15 and Cytek Biosciences, Inc. on 3.
Valuation
Profitability
| Metric | CTKB | TCMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 54.75% | 77.00% | 57.76% |
| Operating margin | (21.13%) | 9.44% | (15.07%) |
| Net margin | (39.10%) | 6.68% | (14.45%) |
| Free cash flow margin | (6.43%) | 8.10% | (3.88%) |
| Return on equity | (23.20%) | 11.02% | (10.35%) |
| Return on assets | (17.26%) | 8.65% | (17.26%) |
| Return on invested capital | (42.08%) | 15.33% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack